ABSTRACT
Purpose Specular and confocal microscopes are important tools to monitor the health of the corneal endothelium (CE), but their high costs significantly limit accessibility in low-resource environments. In our study, we developed and validated a low-cost, fully automated method to quantitatively evaluate the CE using smartphone-based specular microscopy.
Methods A OnePlus 7 Pro smartphone attached to a Topcon SL-D701 slit-lamp was used to image normal the central corneal endothelium using the specular reflection technique. Images were automatically processed on-device and endothelial cell density (ECD), percentage of hexagonal cells (HEX), and coefficient of variation (CV) values were determined using our novel image analysis algorithm. The morphometric parameters generated from the images taken by Tomey EM-4000 specular microscope were compared between the testing modalities.
Results No significant differences in ECD (2799 ± 156 cells/mm2 vs 2779 ± 166 cells/mm2; p=0.28) and HEX (52 ± 6% vs 53 ± 6%; p=0.50) computed by smartphone-based specular imaging and specular microscope, respectively, were found. A statistically significant difference in CV (34 ± 3% vs 30 ± 3%; p<0.01) was found between the two methods. The concordance achieved between the smartphone-based method and the Tomey specular microscope is very similar to the concordance between two specular microscopes reported in the literature.
Conclusions Smartphone-based specular imaging and automated analysis is a low-cost method to quantitatively evaluate the CE with accuracy comparable to the clinical standard.
Translational Relevance This tool can be used to screen the CE in low-resource regions and reveal the need for further investigation of suspected corneal endotheliopathies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors did not receive any funding or compensation for this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional Review Board of the Sri Kiran Institute of Ophthalmology and was in compliance with the Declaration of Helsinki. Informed written consent was obtained from all participants.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data will be made available upon reasonable request.